HOMER L. PEARCE, PH.D. - Corporate Board Profile

Viracta Therapeutics, Inc.

Filing Date	Source Excerpt
2008-04-29	Consistent with these considerations, after a review of all relevant transactions or relationships between each director, or any of his family members, and Sunesis, our senior management and our independent registered public accounting firm, the Board has affirmatively determined that Drs. Evnin, Fodor, Pearce and Stump and Messrs. Fust, Goldby and Leff, a majority of our Board, are independent directors within the meaning of the applicable NASDAQ listing requirements. ... We have entered into consulting agreements with Drs. Pearce, Stump and Wells for consulting services as described in more detail below. ... This amount reflects payments to Dr. Pearce under his consulting agreement with us for consulting services performed in 2007.
2009-05-20	Homer L. Pearce, Ph.D. served in various capacities at Eli Lilly & Company between 1979 and March 2006, including Vice President, Cancer Research and Clinical Investigation from 1994 to 2002 and Distinguished Research Fellow, Cancer Research, Lilly Research Laboratories from 2002 to March 2006. ... On April 3, 2009, Dr. Pearce was appointed chairman of the Nominating and Corporate Governance Committee. ... The following table sets forth the compensation information for our non-employee directors, ... Homer L. Pearce, Ph.D. Fees Earned or Paid in Cash $23,000, Option Awards $48,135, All Other Compensation $6,563, Total $77,698.
2010-04-29	Homer L. Pearce, Ph.D. served in various capacities at Eli Lilly & Company between 1979 and March 2006, including Vice President, Cancer Research and Clinical Investigation from 1994 to 2002 and Distinguished Research Fellow, Cancer Research, Lilly Research Laboratories from 2002 to March 2006. Since August 2006, Dr. Pearce has served as a consultant to Sunesis. Dr. Pearce holds a B.S. from Texas A&M University and a Ph.D. in Organic Chemistry from Harvard University. Dr. Pearce was appointed chairman of the Nominating and Corporate Governance Committee. On the date of our annual meeting of stockholders each year, each non-employee director who serves on a committee is entitled to receive an annual payment of $3,000 for service as a member on a committee and $5,000 for service as chairman of a committee. Dr. Pearce's total compensation for 2009 was $51,684.
2011-04-21	Homer L. Pearce, Ph.D. served in various capacities at Eli Lilly & Company between 1979 and March 2006, including Vice President, Cancer Research and Clinical Investigation from 1994 to 2002 and Distinguished Research Fellow, Cancer Research, Lilly Research Laboratories from 2002 to March 2006. ... The Nominating Committee is chaired by Dr. Pearce and also includes Mr. Misfeldt, each of whom is "independent" within the meaning of applicable SEC rules and NASDAQ listing requirements. ... The Audit Committee is chaired by Mr. Fust, and also includes Mr. Hurwitz and Dr. Stump. ... The following table sets forth the compensation information for our non-employee directors, as well as Dr. Young, the current Chairman of our Board and former Executive Chairman, for the year ended December 31, 2010. ... Homer L. Pearce, Ph.D. Fees Earned or Paid in Cash $37,500, Option Awards $5,393, Total $42,893.
2012-04-23	Homer L. Pearce, Ph.D. served in various capacities at Eli Lilly & Company. Dr. Pearce has served as a consultant to Sunesis. The Board has concluded that Dr. Pearce should serve on our Board due to his scientific expertise. Director Compensation Table shows total compensation of $110,190.
2013-04-25	Homer L. Pearce, Ph.D. served in various capacities at Eli Lilly & Company between 1979 and March 2006, including Vice President, Cancer Research and Clinical Investigation from 1994 to 2002 and Distinguished Research Fellow, Cancer Research, Lilly Research Laboratories from 2002 to March 2006. ... The Nominating Committee is chaired by Dr. Pearce and also includes Mr. Misfeldt, each of whom is independent. ... The following table sets forth the compensation information for our non-employee directors for the year ended December 31, 2012. ... Homer L. Pearce total compensation $87,980.
2014-04-24	Homer L. Pearce, Ph.D. serves as Chairman of the Nominating and Corporate Governance Committee and is a member of the Audit and Compensation Committees. The compensation table shows total compensation of $109,171 for 2013.
2015-04-28	Homer L. Pearce, Ph.D. served in various capacities at Eli Lilly & Company between 1979 and March 2006, including Vice President, Cancer Research and Clinical Investigation from 1994 to 2002 and Distinguished Research Fellow, Cancer Research, Lilly Research Laboratories from 2002 to March 2006. Dr. Pearce is a member of the American Association for Cancer Research, the American Chemical Society and the American Association for the Advancement of Science. Dr. Pearce holds a B.S. from Texas A&M University and a Ph.D. in Organic Chemistry from Harvard University. The Board has concluded that Dr. Pearce should serve on our Board due to his scientific expertise and industry background, which are valuable as we continue our drug development efforts. Director Compensation Table: Homer L. Pearce, Ph.D. Fees Earned or Paid in Cash ($): $47,500, Option Awards ($): $87,038, Total ($): $134,538.
2016-04-25	Homer L. Pearce, Ph.D. served in various capacities at Eli Lilly & Company and is currently a director. The Director Compensation Table shows total compensation of $132,152.
2017-04-20	Homer L. Pearce, Ph.D. served in various capacities at Eli Lilly & Company. ... The Board has concluded that Dr. Pearce should serve on our Board due to his scientific expertise and industry background. ... The following table sets forth the compensation information for our non-employee directors for the year ended December 31, 2016. Homer L. Pearce received total compensation of $69,240.
2018-04-25	Homer L. Pearce, Ph.D. served in various capacities at Eli Lilly & Company between 1979 and March 2006. ... The Board has concluded that Dr. Pearce should serve on our Board due to his scientific expertise and industry background. ... On December 12, 2017, Dr. Pearce was appointed to the Compensation Committee and is chair of the Nominating and Corporate Governance Committee. ... Homer L. Pearce 47,500 fees earned, 58,915 option awards, total 106,415.
2019-04-12	Homer L. Pearce, Ph.D. served in various capacities at Eli Lilly & Company between 1979 and March 2006. ... The Board has concluded that Dr. Pearce should serve on our Board due to his scientific expertise and industry background. ... Committees: Audit Committee, Compensation Committee. ... Director Compensation Table: Homer L. Pearce, Ph.D. Fees Earned or Paid in Cash $56,875, Option Awards $42,740, Total $99,615.
2020-04-28	Homer L. Pearce, Ph.D. served in various capacities at Eli Lilly & Company. The Director Compensation Table shows total compensation of $98,608 for 2019. He serves as Chairman of the Nominating and Corporate Governance Committee and is a member of the Compensation Committee.